Global Head, Biopharma R&D Digital Patient Health, AstraZeneca R&D
The R&D Digital Patient Health group’s mission is to develop digital health solutions which deliver improved clinical outcomes for patients. The group develops tools for use in all phases of the pharmaceutical product lifecycle, delivering its products globally across all therapy areas in which AZ has focus. Having started his career characterising the impact of medication use and misuse on drug delivery Matt is delighted to now be able to deliver tools to patients which robustly improve medication use, collect data directly from patients to support self-management, and improve clinical outcomes.
15 October 2020
BOOK YOUR PLACE NOW